<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03456154</url>
  </required_header>
  <id_info>
    <org_study_id>PPGO022</org_study_id>
    <nct_id>NCT03456154</nct_id>
  </id_info>
  <brief_title>Botox vs Occlusal Splint for Masseter Pain</brief_title>
  <official_title>Use of Botox Versus Conventional Treatment for Pain Decrease of Muscular Pain: a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Federal University of Pelotas</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Federal University of Pelotas</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This randomized clinical trial will compare the standard treatment (occlusal splint) and&#xD;
      botox for the treatment of face muscular pain in adults. Fifty patients will be invited and&#xD;
      selected, and allocated to the experimental group, according to the randomization sequence&#xD;
      previously performed. For the splint group, a rigid splint will be worn by the patient every&#xD;
      night. For the botox group, 60u of botox will be injected in 3 regions of the masseter&#xD;
      muscle. Patients will be assessed before the experiment, 3 and 6 months after the beginning&#xD;
      of the study. Oral health related quality of life, pain, and cervical neck position will be&#xD;
      evaluated. Paired t-test and chi-square will be used for statistical analysis.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 15, 2018</start_date>
  <completion_date type="Actual">March 1, 2021</completion_date>
  <primary_completion_date type="Actual">January 15, 2021</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Masticatory muscle pain</measure>
    <time_frame>baseline, 3 and 6 months</time_frame>
    <description>VAS will be used to assess decrease of pain</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Oral health related quality of life</measure>
    <time_frame>baseline, 3 and 6 months</time_frame>
    <description>OHIP 14 questionnaire will be applied</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cervical Position</measure>
    <time_frame>baseline, 3 and 6 months</time_frame>
    <description>Modifications of cervical vertebral column position will be assessed</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Pain, Face</condition>
  <arm_group>
    <arm_group_label>Botox</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In this group patients will receive 3 injections of botox on each masseter (left and right), after randomization. This injection will be performed once, and the patient will be evaluated after 3 and 6 months after this day.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Occlusal splint</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>In this group patients will receive an occlusal splint, which will be manufactured after taking their full mouth impression. This appliance has to be worn everyday, for 6 months, at night.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Botox Injectable Product</intervention_name>
    <description>60u will be used at 3 sites of masseter muscle, on each side of the face</description>
    <arm_group_label>Botox</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Occlusal splint</intervention_name>
    <description>In this group patients will receive an occlusal splint which will be worn everyday for 6 months at night.</description>
    <arm_group_label>Occlusal splint</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Between 18 and 70 years old;&#xD;
&#xD;
          -  at least 20 teeth in the mouth;&#xD;
&#xD;
          -  occlusal stability;&#xD;
&#xD;
          -  presenting pain in face muscles.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Angle's Class III&#xD;
&#xD;
          -  Kennedy's Class II or I removable partial denture wearer;&#xD;
&#xD;
          -  Complete denture wearer;&#xD;
&#xD;
          -  Individuals that have taken any anti inflammatory drugs in the last 3 months;&#xD;
&#xD;
          -  Individuals with temporomandibular joint disorders.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Federal University of Pelotas</name>
      <address>
        <city>Pelotas</city>
        <state>Rio Grande Do Sul</state>
        <zip>96015560</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>February 28, 2018</study_first_submitted>
  <study_first_submitted_qc>March 5, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 7, 2018</study_first_posted>
  <last_update_submitted>May 18, 2021</last_update_submitted>
  <last_update_submitted_qc>May 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Federal University of Pelotas</investigator_affiliation>
    <investigator_full_name>Maximiliano Sergio Cenci</investigator_full_name>
    <investigator_title>PhD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Facial Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Salicylic Acid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

